EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The influence of cell-cell fusion on cancer heterogeneity and its promise for targeted treatments

Kairui Liu, Jialong Shi, Jiayue Liu, Yue Zhang, Jingjing Liang, Jing Xu, Shuo Chen, Shiwu Zhang

Cellular Oncology · 08.01.2026 · 49 (1)

DOI: 10.1007/s13402-025-01153-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 08.01.2026. Verfasst von Kairui Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Union Medical Center, Tianjin Medical University, Tianjin, 300121, P. R. China. Hauptthemen laut MEDLINE: Cell Fusion, Neoplasms, Molecular Targeted Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell-cell fusion is a common cellular process that occurs in nature. In the physiological environment, cell-cell fusion plays a crucial role in the establishment of homeostasis and the normal development of an organism. Normal cell-cell fusion is related to zygote formation, placental development, muscle growth, and macrophage formation. However, in cancer, cell-cell fusion destabilizes homeostasis and enhances cancer heterogeneity. The fusion of cancer and normal host cells, such as mesenchymal stem cells or white blood cells, promotes cancer growth, metastasis, and immune escape. On the other hand, fusion of cancer cells with each other leads directly to the formation of polyploid giant cancer cells (PGCCs). PGCCs are cancer stem cells considered the root cause of cancer metastasis, chemoradiotherapy resistance and recurrence. The presence of PGCCs significantly promotes the evolution of cancer. Clinical detection and targeted therapies based on cell-cell fusion have rapidly emerged with advancements in cell culture technology, which may bring hope to the treatment of cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell FusionNeoplasmsMolecular Targeted TherapyHumansAnimalsNeoplastic Stem Cells

Stichwörter der Autor:innen

Cell-cell fusionEpithelial-mesenchymal transitionFusion-related proteinsPolyploid giant cancer cells

Autor:innen und Institutionen

  • Tianjin Union Medical Center, Tianjin Medical University, Tianjin, 300121, P. R. China.
  • Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, P.R. China.
  • Department of Pathology, Tianjin Union Medical Center, Tianjin, 300071, P. R. China.
  • Department of General Surgery, Tianjin Union Medical Center, Tianjin, 300121, P. R. China.
  • Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, 300121, P. R. China.
  • Department of Pathology, Tianjin Union Medical Center, Tianjin, 300071, P. R. China. zhangshiwu666@aliyun.com.

Zitieren

APA

Liu, K., Shi, J., Liu, J., Zhang, Y., Liang, J., Xu, J., Chen, S., & Zhang, S. (2026). The influence of cell-cell fusion on cancer heterogeneity and its promise for targeted treatments. Cellular Oncology, 49(1). https://doi.org/10.1007/s13402-025-01153-7

Vancouver

Liu K, Shi J, Liu J, Zhang Y, Liang J, Xu J, et al. The influence of cell-cell fusion on cancer heterogeneity and its promise for targeted treatments. Cellular Oncology. 2026;49(1). doi:10.1007/s13402-025-01153-7

BibTeX
@article{Liu2026,
  author = {Liu, Kairui and Shi, Jialong and Liu, Jiayue and Zhang, Yue and Liang, Jingjing and Xu, Jing and Chen, Shuo and Zhang, Shiwu},
  title = {The influence of cell-cell fusion on cancer heterogeneity and its promise for targeted treatments},
  journal = {Cellular Oncology},
  year = {2026},
  volume = {49},
  number = {1},
  doi = {10.1007/s13402-025-01153-7}
}
Kostenlos starten →